Acrivon Therapeutics, Inc. (ACRV) — Dilution Risk Analysis

Current Snapshot

Acrivon Therapeutics, Inc. (ACRV) has a DilutionWatch score of 42/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
42,853,362 Source
Public Float
16,870,317 Source
Float as % of Outstanding
39.4%

Dilution Risk Score

Score: 42/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 3 1, 4 7, FORM 4 2.

FormFiledAccession
3 2026-09-02 0000905148-26-004064
4 2026-09-02 0000905148-26-004065
4 2026-08-27 0000905148-26-003968
Form 4 2026-08-25 0000905148-26-003968|0001950499|2026-08-25|S|14036
4 2026-08-20 0000905148-26-003836
4 2026-08-20 0000905148-26-003837
4 2026-08-20 0000905148-26-003838
4 2026-08-20 0000905148-26-003839
4 2026-08-20 0000905148-26-003840
Form 4 2026-08-18 0000905148-26-003840|0002022214|2026-08-18|S|101

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 15 months Source
Three-year share count growth 93.08% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 42/10) Source
Cash Runway
15 months Source
Share Count Growth (3-Year)
93.08% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.